Skip to main content
. 2021 May 26;8:665713. doi: 10.3389/fvets.2021.665713

Table 3.

Median (range) peak height of fecal metabolites with significant group-by-time interactions or concurrent group and time effects for dogs that received enrofloxacin/metronidazole followed by placebo or synbiotic for 21 days.

Placebo Synbiotic fdr P-value
Baseline Days 26–28 Days 82–84 Baseline Days 26–28 Days 82–84 Group* Time Group Time
1-deoxyerythritol 3,943a,β (2,376–6,884) 1,759c,β (1,115–3,795) 2,573b,β (1,251–10,686) 5,810a,α (3,564–10,619) 3,286c,α (1,783–4,037) 3,514b,α (2,194–5,834) <0.01 <0.01
2-hydroxyglutaric acid 617bc (351–1,769) 752b (269–8,379) 961b (242–3,611) 497cd (264–881) 2,999a (734–10,872) 336d (185–733) <0.01 <0.01
2-monoolein 13,913a (9,341–31,985) 4,732c (2,417–9,397) 10,091b (4,217–15,122) 10,370b (996–23,452) 4,657c (2,260–9,157) 14,264ab (5,223–17,870) 0.02 <0.01
3-phenyllactic acid 1,589d (621–6,453) 20,424a (13,289–58,071) 12,004b (2,943–26,814) 2,804cd (1,659–7,204) 35,635a (25,628–54,631) 5,172c (1,561–10,187) 0.02 <0.01
Allantoic acid 574ab (346–9,428) 363ab (57–5,302) 372b (98–1,417) 479b (262–7,659) 525b (71–8,130) 1,060a (237–8,365) 0.045
Behenic acid 17,039a (10,554–27,314) 12,039b (5,630–33,623) 8,485c (6,598–16,857) 18,397a (5,337–37,951) 8,169c (4,824–16,919) 9,831bc (3,974–17,712) 0.045 <0.01
Butane-2,3-diol NIST 3,568c (2,699–7,200) 66,839ab (1,848–177,389) 14,081ab (1,978–946,157) 5,832bc (2,181–74,843) 73,860a (4,516–207,742) 3,401c (831–20,343) <0.01 <0.01
Cholesterol 149,365a,α (103,904–195,152) 75,299c,α (32,531–146,078) 83,947b,α (55,654–152,213) 100,350a,β (75,261–321,230) 52,181c,β (37,103–73,759) 87,172b,β (51,653–178,799) 0.04 <0.01
Daidzein 473b,β (251–5,277) 9,026a,β (2,351–11,387) 368b,β (217–9,333) 921b,α (448–15,926) 8,394a,α (1,659–15,777) 5,369b,α (397–15,651) 0.01 <0.01
Deoxycholic acid 420,927a (287,558–1,547,882) 2,962cd (1,273–413,873) 149,001c (872–267,037) 225,249b (110,916–674,640) 2,284d (733–6,615) 255,829b (3,037–756,630) 0.02 <0.01
D-erythro-sphingosine 6,805a (2,526–29,549) 3,756bc (975–18,571) 2,036cd (915–5,138) 4,890ab (955–11,023) 1,622d (672–9,162) 4,518ab (3,092–14,801) 0.01 <0.01
Docosahexaenoic acid 17,299a,α (13,147–48,544) 5,222c,α (988–12,968) 16,575b,α (7,393–31,581) 11,549a,β (6,307–34,081) 1,527c,β (1,433–5,486) 10,141b,β (2,105–18,520) 0.02 <0.01
Erythritol 4,250b,β (2,176–21,769) 13,219a,β (1,480–31,839) 913c,β (413–11,712) 4,025b,α (907–19,062) 24,525a,α (20,722–46,236) 2,312c,α (852–10,345) 0.01 <0.01
Ferulic acid 1,192bc (652–1,736) 1,920ab (408–4,344) 563d (137–1,194) 861cd (405–1,233) 2,122a (1,300–3,853) 964bc (522–2,479) 0.03 <0.01
Fucose 179,811a (41,782–233,563) 137,082a (3,849–837,808) 13,332c (8,185–320,277) 137,859ab (50,951–233,808) 68,870bc (1,751–169,428) 120,553ab (17,516–264,172) 0.01
Galactinol 695b,β (534–1,667) 981a,β (823–2,975) 522c,β (303–1,023) 1,050b,α (518–2,174) 1,893a,α (1,219–3,985) 500c,α (279–1,951) 0.047 <0.01
Galactose 163,560a (56,259–288,199) 39,870bc (19,078–237,206) 24,910cd (8,818–308,074) 102,098ab (46,025–202,159) 27,749d (7,301–69,499) 121,530ab (28,291–493,825) 0.03 <0.01
Glutamic acid 121,446b (95,863–179,885) 250,811a (116,078–408,091) 132,799b (60,403–435,886) 135,038b (95,213–274,191) 275,893a (162,620–470,665) 80,460c (30,579–124,299) 0.01 <0.01
Glutaric acid 896a,β (426–1,641) 768a,β (318–3,303) 470b,β (303–1,245) 1,141a,α (554–2,124) 1,343a,α (530–8,514) 573b,α (519–1,390) 0.03 <0.01
Glycerol-alpha-phosphate 1,332c (130–2,070) 2,743b (774–4,096) 1,420bc (774–2,365) 1,055c (95–2,587) 3,960a (2,865–5,321) 1,224c (253–1,980) 0.03 <0.01
Hexadecylglycerol NIST 6,021a,α (4,332–11,689) 2,783c,α (620–3,860) 4,273b,α (1,897–5,447) 3,592a,β (2,727–12,350) 1,632c,β (678–3,580) 2,959b,β (1,246–5,882) 0.02 <0.01
Indole-3-propionic acid 14,629a,α (8,342–41,807) 6,359b,α (273–11,067) 21,609a,α (11,397–213,321) 9,929a,β (6,433–39,621) 4,103b,β (122–8,132) 9,006a,β (5,149–261,311) 0.01 <0.01
Inosine 843a (191–18,392) 178c (103–4,221) 437b (134–6,505) 2,812a (475–16,194) 145c (96–253) 6,424a (417–12,002) 0.01 <0.01
Isoleucine 218,417c (144,351–405,106) 382,705ab (274,560–647,973) 442,249a (270,033–602,789) 295,250ab (214,178–674,190) 322,186b (183,901–691,552) 420,279a (250,849–929,432) 0.02 <0.01
Linoleic acid 31,003a,α (19,842–58,595) 6,812b,α (2,085–17,820) 25,853a,α (12,932–47,171) 14,912a,β (8,022–36,173) 4,846b,β (1,882–8,382) 25,814a,β (11,785–33,998) 0.02 <0.01
Lysine 91,686a,α (59,571–204,631) 37,443b,α (4,793–129,197) 195,379a,α (4,376–244,884) 88,520a,β (35,630–172,381) 37,148b,β (19,483–63,945) 75,462a,β (8,834–135,588) 0.04 <0.01
Maltose 3,321ab (1,174–15,494) 2,055b (443–12,081) 5,510a (990–13,210) 2,142b (1,296–12,555) 4,835a (1,370–26,980) 2,483b (1,114–6,542) 0.02
Methionine sulfoxide 25,019b,α (16,164–32,096) 15,187c,α (3,893–40,207) 43,425a,α (24,804–61,200) 27,844b,β (9,120–42,782) 10,510c,β (5,714–17,172) 29,577a,β (7,316–54,293) 0.02 <0.01
N-acetylglutamate 611a (452–1,813) 545a (306–1,779) 856a (251–3,533) 585a (418–2,128) 570a (269–2,982) 253b (189–1,387) 0.02
Ornithine 39,943b,α (7,429–60,274) 32,926b,α (3,931–67,775) 106,782a,α (37,067–161,661) 41,914b,β (14,623–55,508) 31,069b,β (13,064–44,642) 38,525a,β (14,556–67,033) <0.01 0.01
Oxoproline 61,545bc (54,924–112,476) 340,035a (82,079–490,827) 91,480b (48,067–308,646) 75,373bc (48,333–228,173) 390,081a (316,439–630,055) 50,243c (38,250–137,407) 0.03 <0.01
Phenylacetic acid 4,975b (3,312–24,386) 1,324c (446–6,138) 9,494ab (3,106–20,887) 11,517a (3,607–50,106) 908c (626–3,941) 9,363ab (2,780–23,596) 0.04 <0.01
P-hydroxylphenyllactic acid 552c (305–1,332) 2,802a (990–7,942) 2,157b (747–5,019) 645c (236–3,049) 5,232a (1,761–8,091) 856c (402–1,859) 0.01 <0.01
Phytosphingosine 6,552a (4,474–14,350) 3,373bc (1,053–36,357) 5,011bc (2,568–5,546) 4,056c (1,714–8,857) 2,686d (1,639–6,759) 5,229ab (3,312–11,865) 0.02 <0.01
Resorcinol 1,122a (263–1,440) 86c (60–144) 298b (127–1,160) 417b (147–2,294) 89c (67–107) 543b (121–1,962) 0.03 <0.01
Ribonic acid 1,295bc (841–2,265) 2,623a (1,690–6,569) 1,252b (659–2,982) 1,182bc (412–1,987) 3,303a (2,363–4,531) 961c (509–1,395) 0.03 <0.01
Sinapinic acid 793b,β (195–1,046) 1,872a,β (358–4,872) 593b,β (459–776) 776b,α (561–1,769) 2,750a,α (1,008–5,776) 782b,α (531–1,458) 0.02 <0.01
Sorbitol 7,753a,β (1,676–58,914) 5,530a,β (1,395–51,870) 1,853b,β (1,049–2,261) 5,343a,α (2,302–44,389) 9,181a,α (3,005–54,449) 3,107b,α (656–7,939) 0.02 <0.01
Thymidine 9,507a,α (4,687–14,694) 2,350c,α (1,095–7,641) 7,075b,α (1,920–11,952) 7,150a,β (4,227–11,471) 1,826c,β (823–3,809) 4,999b,β (1,774–12,346) 0.046 <0.01
Thymine 46,343b (27,601–68,823) 8,471d (3,608–26,848) 30,637c (17,424–50,012) 68,273a (43,452–77,166) 6,774d (4,152–15,770) 45,188bc (24,105–75,344) 0.04 <0.01
Tocopherol acetate 2,491a,β (1,105–7,290) 1,728b,β (379–3,256) 1,764b,β (817–5,111) 5,993a,α (1,472–8,182) 2,087b,α (934–3,937) 3,653b,α (760–10,497) 0.03 <0.01
Trans-4-hydroxyproline 9,801b,β (5,163–14,095) 12,876a,β (6,879–29,372) 10,814b,β (6,362–22,934) 14,413b,α (6,857–26,266) 22,303a,α (15,712–34,354) 12,084b,α (8,242–21,617) 0.01 <0.01
Trehalose 818c (267–39,653) 3,345b (424–15,841) 1,446bc (355–4,849) 1,515bc (469–33,179) 24,151a (949–67,966) 612c (289–5,888) 0.04 <0.01
Tyramine 144,932cd (44,639–798,913) 465,802a (273,758–710,593) 95,257d (14,855–160,213) 227,211bc (6,229–739,225) 344,927ab (222,062–866,039) 387,329ab (81,658–1,045,046) 0.02 <0.01
Uridine 2,015a (779–6,617) 791b (426–3,758) 1,089b (614–4,056) 2,317a (1,511–17,296) 923b (520–1,473) 4,861a (1,110–10,101) 0.01 0.01 <0.01
Urocanic acid 1,247a,β (733–2,876) 1,023b,β (263–3,379) 1,406a,β (598–3,396) 2,186a,α (869–3,699) 1,114b,α (420–2,808) 1,950a,α (1,220–2,390) 0.03 0.03
Xanthosine 494a (204–2,836) 98c (47–641) 195b (60–1,004) 774a (290–2,233) 102c (76–123) 543a (281–1,597) 0.02 <0.01

Profiles that do not share a common superscript letter differed significantly (fdr-adjusted P < 0.05) based on post-hoc analysis.